APA (7th ed.) Citation

Pina-Cabral, T., Pereira, J., Paulo-Fernandes, J., Silva, M., Fontes-Sousa, M., Anacleto, M., . . . Cavaco, P. (2026). Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance. Cancers, 18(1), 76. https://doi.org/10.3390/cancers18010076

Chicago Style (17th ed.) Citation

Pina-Cabral, Tiago, et al. "Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance." Cancers 18, no. 1 (2026): 76. https://doi.org/10.3390/cancers18010076.

MLA (9th ed.) Citation

Pina-Cabral, Tiago, et al. "Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance." Cancers, vol. 18, no. 1, 2026, p. 76, https://doi.org/10.3390/cancers18010076.